1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9619):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W753344
    2-(2,6-Dichlorophenoxy)-N-phenylacetamide-13C6
    2-(2,6-Dichlorophenoxy)-N-phenylacetamide-13C6 is the 13C-labeled 2-(2,6-Dichlorophenoxy)-N-phenylacetamide (HY-W713396).
    2-(2,6-Dichlorophenoxy)-N-phenylacetamide-<sup>13</sup>C<sub>6</sub>
  • HY-W039173S
    4-(Methylamino)butanoic acid-d9 hydrochloride
    4-(Methylamino)butanoic acid-d9 hydrochloride is the deuterium labeled 4-(Methylamino)butanoic acid hydrochloride.
    4-(Methylamino)butanoic acid-d<sub>9</sub> hydrochloride
  • HY-W741285
    Glycidyl laurate-d5
    Glycidyl laurate-d5 is the deuterium labeled Glycidyl Laurate (HY-W127405). Glycidyl Laurate is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Glycidyl laurate-d<sub>5</sub>
  • HY-W009216S2
    2'-Deoxycytidine-5'-monophosphate-15N3,d12 dilithium
    2'-Deoxycytidine-5'-monophosphoric acid-15N3,d12 dilithium is deuterium and 15N labeled 2'-Deoxycytidine-5'-monophosphoric acid (HY-W009216). 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite.
    2'-Deoxycytidine-5'-monophosphate-<sup>15</sup>N<sub>3</sub>,d<sub>12</sub> dilithium
  • HY-W747845
    1-Methyllysergol-d3
    1-Methyllysergol-d3 is the deuterium labeled 1-Methyllysergol.
    1-Methyllysergol-d<sub>3</sub>
  • HY-W778920
    5α-Cholestan-3β-ol-d7
    5α-Cholestan-3β-ol-d7 (Dihydrocholesterol-d7; 5α-Cholestanol-d7; NSC 18188-d7) is the deuterium labeled 5α-Cholestan-3β-ol (HY-107819). 5α-Cholestan-3β-ol is a derivitized steroid compound.
    5α-Cholestan-3β-ol-d<sub>7</sub>
  • HY-146937S
    CER11-2’S-d9
    CER11-2’S-d9 is deuterium labeled CER11-2’S.
    CER11-2’S-d<sub>9</sub>
  • HY-W777188
    6-Hydroxy Chlorzoxazone-13C6
    6-Hydroxy Chlorzoxazone-13C6 is a the 13C-labeled 6-Hydroxy Chlorzoxazone (HY-W016221). 6-Hydroxy Chlorzoxazone is a metabolite of Chlorzoxazone (HY-B1462). Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort.
    6-Hydroxy Chlorzoxazone-13C6
  • HY-B0640S
    Epinastine-13C,d3 hydrobromide
    Epinastine-13C,d3 (hydrobromide) is the 13C- and deuterium labeled Epinastine. Epinastine (WAL801) is an antihistamine and mast cell stabilizer. Epinastine is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine also inhibits IL-8 release and has an antiallergic action.
    Epinastine-<sup>13</sup>C,d<sub>3</sub> hydrobromide
  • HY-B0241S1
    Ipratropium-d7 bromide
    Ipratropium-d7 (bromide)eis the deuterium labeled Ipratropium bromide. Ipratropium bromide (Sch 1000) is a muscarinic receptor antagonist, with binding IC50 values of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma.
    Ipratropium-d<sub>7</sub> bromide
  • HY-150665S
    N-Dansyl-d6 1,4-diaminobutane, 97% (CP)
    N-Dansyl-d6 1,4-diaminobutane, 97% (CP) is the deuterium labeled N-Dansyl 1,4-diaminobutane, 97% (CP).
    N-Dansyl-d<sub>6</sub> 1,4-diaminobutane, 97% (CP)
  • HY-15027S
    5-Aminosalicylic Acid-d3 hydrochloride
    99.00%
    5-Aminosalicylic Acid-d3 (hydrochloride) is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) hydrochloride acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.
    5-Aminosalicylic Acid-d<sub>3</sub> hydrochloride
  • HY-W771020
    2-(Dodecyloxy)ethanol-d25
    2-(Dodecyloxy)ethanol-d25 (Ethylene glycol monododecyl ether-d25) is the deuterium labeled 2-(Dodecyloxy)ethanol (HY-W250300). 2-(Dodecyloxy)ethanol is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    2-(Dodecyloxy)ethanol-d<sub>25</sub>
  • HY-122272S2
    Paroxetine-d6-1
    Paroxetine-d6-1 is a deuterated labeled Paroxetine. Paroxetine, a phenylpiperidine derivative, is a potent and selective serotonin reuptake inhibitor (SSRI). Paroxetine is a very weak inhibitor of norepinephrine (NE) uptake but it is still more potent at this site than the other SSRIs.
    Paroxetine-d<sub>6</sub>-1
  • HY-77956S
    Thyminose-13C
    Thyminose-13C is the 13C labeled Thyminose. Thyminose is an endogenous metabolite.
    Thyminose-<sup>13</sup>C
  • HY-141907S
    17β-Estradiol-13C3
    98.1%
    17β-Estradiol-13C3 is the 13C labeled 17β-Estradiol.
    17β-Estradiol-<sup>13</sup>C<sub>3</sub>
  • HY-W392933S5
    Thymidine 5'-monophosphate-d13 dilithium
    Thymidine 5'-monophosphate-d13 (Thymidine-5'-phosphate-d13) dilithium is deuterium labeled Thymidine 5'-monophosphate (HY-W392933).
    Thymidine 5'-monophosphate-d<sub>13</sub> dilithium
  • HY-17021S
    Esomeprazole-d3 sodium
    Esomeprazole-d3 (sodium) is the deuterium labeled Esomeprazole. Esomeprazole ((S)-Omeprazole) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H+, K+-ATPase in gastric parietal cells. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research.
    Esomeprazole-d<sub>3</sub> sodium
  • HY-10582S3
    Flurbiprofen-d4
    Flurbiprofen-d4 is deuterated labeled Flurbiprofen (HY-10582). Flurbiprofen (dl-Flurbiprofen) is a potent, orally active nonsteroidal anti-inflammatory agent (NSAIA/NSAID), with antipyretic and analgesic activities. Flurbiprofen is commonly used for the research of inflammatory diseases, including osteoarthritis and rheumatoid arthritis. Flurbiprofen is a non-selective cyclooxygenase (COX) inhibitor that can be used for the research of colorectal cancer.
    Flurbiprofen-d<sub>4</sub>
  • HY-150628S
    2-Oxobutanoic acid-13C,d1 sodium hydrate
    2-Oxobutanoic acid-13C,d1 sodium hydrate is the deuterium and 13C labeled 2-Oxobutanoic acid sodium hydrate.
    2-Oxobutanoic acid-<sup>13</sup>C,d<sub>1</sub> sodium hydrate